Previous 10 | Next 10 |
Class-action law firm urges OMCL investors to learn their shareholder rights against Omnicell SAN FRANCISCO, CA / ACCESSWIRE / September 15, 2019 / Hagens Berman reminds investors in Omnicell, Inc. (NASDAQ:OMCL) of the September 16, 2019 deadline to move for lead plaintiff in a fede...
Class-action law firm urges OMCL investors to learn their shareholder rights against Omnicell SAN FRANCISCO, CA / ACCESSWIRE / September 14, 2019 / Hagens Berman reminds investors in Omnicell, Inc. (NASDAQ:OMCL) of the September 16, 2019 deadline to move for lead plaintiff in a fede...
Class-action law firm urges OMCL investors to learn their shareholder rights against Omnicell SAN FRANCISCO, CA / ACCESSWIRE / September 13, 2019 / Hagens Berman reminds investors in Omnicell, Inc. (NASDAQ:OMCL) of the September 16, 2019 deadline to move for lead plaintiff in a fede...
Class-action law firm urges OMCL investors to learn their shareholder rights against Omnicell SAN FRANCISCO, CA / ACCESSWIRE / September 12, 2019 / Hagens Berman reminds investors in Omnicell, Inc. (NASDAQ:OMCL) of the September 16, 2019 deadline to move for lead plaintiff in a fe...
Class-action law firm urges OMCL investors to learn their shareholder rights against Omnicell SAN FRANCISCO, CA / ACCESSWIRE / September 4, 2019 / Hagens Berman reminds investors in Omnicell, Inc. (NASDAQ:OMCL) of the September 16, 2019 deadline to move for lead plaintiff in a feder...
SAN FRANCISCO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Omnicell, Inc. (NASDAQ: OMCL) of the September 16, 2019 deadline to move for lead plaintiff in a federal securities class action pending against the Company. If you invested in Omnicell between Octo...
SAN FRANCISCO, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Omnicell, Inc. (NASDAQ: OMCL) of the September 16, 2019 deadline to move for lead plaintiff in a federal securities class action pending against the Company. If you invested in Omnicell between Octob...
Omnicell, Inc. (NASDAQ:OMCL) a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that Randall Lipps, founder, chairman, president and CEO, and Peter Kuipers, executive vice president and CFO, will be presenting at th...
Combination of technology and intelligence designed to enable pharmacists to operate at the top of their license and provide best possible patient care Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions, including adherence tools for pharmacies, health...
SAN FRANCISCO , CA / ACCESSWIRE / August 13, 2019 / Hagens Berman Sobol Shapiro LLP reminds investors in Omnicell, Inc. (NASDAQ:OMCL) to the securities class action, Bursick v. Omnicell, Inc. et al., No. 3:19cv04150, filed in the U.S. District Court for the Northern District of...
News, Short Squeeze, Breakout and More Instantly...
FRANKLIN, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"),...
Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced XT Amplify, a multi...
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the first quarter 2024, before market open on Thursday, May 2, 2024. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET...